GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0000226 | Microtubule cytoskeleton organization |
| Process | GO:0001817 | Regulation of cytokine production |
| Process | GO:0001819 | Positive regulation of cytokine production |
| Process | GO:0001906 | Cell killing |
| Process | GO:0002376 | Immune system process |
| Process | GO:0005975 | Carbohydrate metabolic process |
| Process | GO:0005996 | Monosaccharide metabolic process |
| Process | GO:0006006 | Glucose metabolic process |
| Process | GO:0006007 | Glucose catabolic process |
| Process | GO:0006082 | Organic acid metabolic process |
| Process | GO:0006090 | Pyruvate metabolic process |
| Process | GO:0006091 | Generation of precursor metabolites and energy |
| Process | GO:0006094 | Gluconeogenesis |
| Process | GO:0006096 | Glycolytic process |
| Process | GO:0006139 | Nucleobase-containing compound metabolic process |
| Process | GO:0006163 | Purine nucleotide metabolic process |
| Process | GO:0006165 | Nucleoside diphosphate phosphorylation |
| Process | GO:0006417 | Regulation of translation |
| Process | GO:0006725 | Cellular aromatic compound metabolic process |
| Process | GO:0006734 | NADH metabolic process |
| Process | GO:0006735 | NADH regeneration |
| Process | GO:0006753 | Nucleoside phosphate metabolic process |
| Process | GO:0006757 | ATP generation from ADP |
| Process | GO:0006793 | Phosphorus metabolic process |
| Process | GO:0006796 | Phosphate-containing compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006955 | Immune response |
| Process | GO:0006959 | Humoral immune response |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007010 | Cytoskeleton organization |
| Process | GO:0007017 | Microtubule-based process |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007565 | Female pregnancy |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008219 | Cell death |
| Process | GO:0009056 | Catabolic process |
| Process | GO:0009058 | Biosynthetic process |
| Process | GO:0009117 | Nucleotide metabolic process |
| Process | GO:0009132 | Nucleoside diphosphate metabolic process |
| Process | GO:0009135 | Purine nucleoside diphosphate metabolic process |
| Process | GO:0009141 | Nucleoside triphosphate metabolic process |
| Process | GO:0009144 | Purine nucleoside triphosphate metabolic process |
| Process | GO:0009150 | Purine ribonucleotide metabolic process |
| Process | GO:0009179 | Purine ribonucleoside diphosphate metabolic process |
| Process | GO:0009185 | Ribonucleoside diphosphate metabolic process |
| Process | GO:0009199 | Ribonucleoside triphosphate metabolic process |
| Process | GO:0009205 | Purine ribonucleoside triphosphate metabolic process |
| Process | GO:0009259 | Ribonucleotide metabolic process |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009620 | Response to fungus |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010466 | Negative regulation of peptidase activity |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010558 | Negative regulation of macromolecule biosynthetic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010605 | Negative regulation of macromolecule metabolic process |
| Process | GO:0010608 | Post-transcriptional regulation of gene expression |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010629 | Negative regulation of gene expression |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010656 | Negative regulation of muscle cell apoptotic process |
| Process | GO:0010660 | Regulation of muscle cell apoptotic process |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010951 | Negative regulation of endopeptidase activity |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016051 | Carbohydrate biosynthetic process |
| Process | GO:0016052 | Carbohydrate catabolic process |
| Process | GO:0016310 | Phosphorylation |
| Process | GO:0017014 | Protein nitrosylation |
| Process | GO:0017148 | Negative regulation of translation |
| Process | GO:0018119 | Peptidyl-cysteine S-nitrosylation |
| Process | GO:0018193 | Peptidyl-amino acid modification |
| Process | GO:0018198 | Peptidyl-cysteine modification |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019318 | Hexose metabolic process |
| Process | GO:0019319 | Hexose biosynthetic process |
| Process | GO:0019320 | Hexose catabolic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019637 | Organophosphate metabolic process |
| Process | GO:0019674 | NAD metabolic process |
| Process | GO:0019693 | Ribose phosphate metabolic process |
| Process | GO:0019730 | Antimicrobial humoral response |
| Process | GO:0019752 | Carboxylic acid metabolic process |
| Process | GO:0019932 | Second-messenger-mediated signaling |
| Process | GO:0019933 | cAMP-mediated signaling |
| Process | GO:0019935 | Cyclic-nucleotide-mediated signaling |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0030162 | Regulation of proteolysis |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031327 | Negative regulation of cellular biosynthetic process |
| Process | GO:0031640 | Killing of cells of another organism |
| Process | GO:0031647 | Regulation of protein stability |
| Process | GO:0032479 | Regulation of type I interferon production |
| Process | GO:0032481 | Positive regulation of type I interferon production |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032787 | Monocarboxylic acid metabolic process |
| Process | GO:0034097 | Response to cytokine |
| Process | GO:0034248 | Regulation of cellular amide metabolic process |
| Process | GO:0034249 | Negative regulation of cellular amide metabolic process |
| Process | GO:0034341 | Response to interferon-gamma |
| Process | GO:0034391 | Regulation of smooth muscle cell apoptotic process |
| Process | GO:0034392 | Negative regulation of smooth muscle cell apoptotic process |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0035556 | Intracellular signal transduction |
| Process | GO:0035606 | Peptidyl-cysteine S-trans-nitrosylation |
| Process | GO:0036211 | Protein modification process |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043066 | Negative regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043069 | Negative regulation of programmed cell death |
| Process | GO:0043086 | Negative regulation of catalytic activity |
| Process | GO:0043122 | Regulation of I-kappaB kinase/NF-kappaB signaling |
| Process | GO:0043123 | Positive regulation of I-kappaB kinase/NF-kappaB signaling |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0043412 | Macromolecule modification |
| Process | GO:0043436 | Oxoacid metabolic process |
| Process | GO:0044092 | Negative regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044281 | Small molecule metabolic process |
| Process | GO:0044282 | Small molecule catabolic process |
| Process | GO:0044283 | Small molecule biosynthetic process |
| Process | GO:0044403 | Biological process involved in symbiotic interaction |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0044703 | Multi-organism reproductive process |
| Process | GO:0044706 | Multi-multicellular organism process |
| Process | GO:0045087 | Innate immune response |
| Process | GO:0045861 | Negative regulation of proteolysis |
| Process | GO:0046031 | ADP metabolic process |
| Process | GO:0046034 | ATP metabolic process |
| Process | GO:0046364 | Monosaccharide biosynthetic process |
| Process | GO:0046365 | Monosaccharide catabolic process |
| Process | GO:0046483 | Heterocycle metabolic process |
| Process | GO:0046939 | Nucleotide phosphorylation |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050821 | Protein stabilization |
| Process | GO:0050832 | Defense response to fungus |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051172 | Negative regulation of nitrogen compound metabolic process |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051248 | Negative regulation of protein metabolic process |
| Process | GO:0051336 | Regulation of hydrolase activity |
| Process | GO:0051346 | Negative regulation of hydrolase activity |
| Process | GO:0051402 | Neuron apoptotic process |
| Process | GO:0051702 | Biological process involved in interaction with symbiont |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051873 | Killing by host of symbiont cells |
| Process | GO:0052547 | Regulation of peptidase activity |
| Process | GO:0052548 | Regulation of endopeptidase activity |
| Process | GO:0055086 | Nucleobase-containing small molecule metabolic process |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060359 | Response to ammonium ion |
| Process | GO:0060548 | Negative regulation of cell death |
| Process | GO:0061615 | Glycolytic process through fructose-6-phosphate |
| Process | GO:0061620 | Glycolytic process through glucose-6-phosphate |
| Process | GO:0061621 | Canonical glycolysis |
| Process | GO:0061718 | Glucose catabolic process to pyruvate |
| Process | GO:0061844 | Antimicrobial humoral immune response mediated by antimicrobial peptide |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0070997 | Neuron death |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071345 | Cellular response to cytokine stimulus |
| Process | GO:0071346 | Cellular response to interferon-gamma |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0072521 | Purine-containing compound metabolic process |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0098542 | Defense response to other organism |
| Process | GO:1901135 | Carbohydrate derivative metabolic process |
| Process | GO:1901360 | Organic cyclic compound metabolic process |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901575 | Organic substance catabolic process |
| Process | GO:1901576 | Organic substance biosynthetic process |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1902531 | Regulation of intracellular signal transduction |
| Process | GO:1902533 | Positive regulation of intracellular signal transduction |
| Process | GO:1905459 | Regulation of vascular associated smooth muscle cell apoptotic process |
| Process | GO:1905460 | Negative regulation of vascular associated smooth muscle cell apoptotic process |
| Process | GO:2000112 | Regulation of cellular macromolecule biosynthetic process |
| Process | GO:2000113 | Negative regulation of cellular macromolecule biosynthetic process |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005811 | Lipid droplet |
| Component | GO:0005829 | Cytosol |
| Component | GO:0005856 | Cytoskeleton |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0014069 | Postsynaptic density |
| Component | GO:0015630 | Microtubule cytoskeleton |
| Component | GO:0016020 | Membrane |
| Component | GO:0030054 | Cell junction |
| Component | GO:0032279 | Asymmetric synapse |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0045202 | Synapse |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097452 | GAIT complex |
| Component | GO:0098794 | Postsynapse |
| Component | GO:0098978 | Glutamatergic synapse |
| Component | GO:0098984 | Neuron to neuron synapse |
| Component | GO:0099091 | Postsynaptic specialization, intracellular component |
| Component | GO:0099092 | Postsynaptic density, intracellular component |
| Component | GO:0099572 | Postsynaptic specialization |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:1990904 | Ribonucleoprotein complex |
| Function | GO:0000166 | Nucleotide binding |
| Function | GO:0003824 | Catalytic activity |
| Function | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
| Function | GO:0004857 | Enzyme inhibitor activity |
| Function | GO:0004866 | Endopeptidase inhibitor activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0008017 | Microtubule binding |
| Function | GO:0008092 | Cytoskeletal protein binding |
| Function | GO:0015631 | Tubulin binding |
| Function | GO:0016491 | Oxidoreductase activity |
| Function | GO:0016620 | Oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor |
| Function | GO:0016740 | Transferase activity |
| Function | GO:0016769 | Transferase activity, transferring nitrogenous groups |
| Function | GO:0016903 | Oxidoreductase activity, acting on the aldehyde or oxo group of donors |
| Function | GO:0019828 | Aspartic-type endopeptidase inhibitor activity |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0019904 | Protein domain specific binding |
| Function | GO:0030234 | Enzyme regulator activity |
| Function | GO:0030414 | Peptidase inhibitor activity |
| Function | GO:0035605 | Peptidyl-cysteine S-nitrosylase activity |
| Function | GO:0036094 | Small molecule binding |
| Function | GO:0042802 | Identical protein binding |
| Function | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity |
| Function | GO:0050661 | NADP binding |
| Function | GO:0051287 | NAD binding |
| Function | GO:0061134 | Peptidase regulator activity |
| Function | GO:0061135 | Endopeptidase regulator activity |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0097718 | Disordered domain specific binding |
| Function | GO:0098772 | Molecular function regulator activity |
| Function | GO:0140096 | Catalytic activity, acting on a protein |
| Function | GO:1901265 | Nucleoside phosphate binding |
| Function | GO:1901363 | Heterocyclic compound binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1430728 | Metabolism |
| RCTM | RNO-70171 | Glycolysis |
| RCTM | RNO-70263 | Gluconeogenesis |
| RCTM | RNO-70326 | Glucose metabolism |
| RCTM | RNO-71387 | Metabolism of carbohydrates |
| WikiPathways | WP2562 | Relationship between glutathione and NADPH |
| WikiPathways | WP3916 | Hexoses metabolism in proximal tubules |
| KEGG | rno00010 | Glycolysis / Gluconeogenesis |
| KEGG | rno01100 | Metabolic pathways |
| KEGG | rno01200 | Carbon metabolism |
| KEGG | rno01230 | Biosynthesis of amino acids |
| KEGG | rno04066 | HIF-1 signaling pathway |
| KEGG | rno05010 | Alzheimer disease |
| KEGG | rno05132 | Salmonella infection |
| KEGG | rno05415 | Diabetic cardiomyopathy |
Expression profile of Gapdh in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 15.960824333333333 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 15.853203333333333 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 15.834055999999999 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 15.949360333333333 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 15.697823999999999 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 16.033598666666666 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 15.950935833333332 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 16.030668666666667 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 16.031399333333333 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 15.416811666666666 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 15.370793333333333 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 15.718574333333335 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 15.821693666666667 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 15.751384666666667 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 15.622250333333334 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 15.489920666666668 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 15.866212666666668 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 15.809759499999998 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 15.868953666666668 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 15.774788000000001 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 15.870835333333334 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 15.752876666666666 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 15.696511333333333 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 15.700810333333335 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.89944742 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.85063376 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.8403124 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.74943013 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.80001702 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 10.70084958 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 5921.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 5124.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 6999.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 3842.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6562.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6353.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6339.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 14849.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4560.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 5559.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4506.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 8477.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 4101.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 5088.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6040.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 5485.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 12.08656 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 12.07298 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 11.97207 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 11.93366 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 12.01213 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 11.97211 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 1815.91 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 1499.595 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 1582.862 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 1530.925 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 2000.069 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 13.450378019999999 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 13.4351150575 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 13.54545031 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 16516.0 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 16377.85 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 16454.399999999998 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 17361.45 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 12232.199999999999 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 20957.333333333332 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 20360.25 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 18663.4 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 21987.86666666667 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 18322.266666666666 | |
| GSM27494 | CTL_a (control, 1st replicate) | 16888.350000000002 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 17316.399999999998 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 22101.649999999998 | |
| GSM27497 | CTL_d (control, 4th replicate) | 15167.65 | |
| GSM27498 | CTL_e (control, 5th replicate) | 16866.233333333334 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 14483.616666666667 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 15507.15 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 14629.016666666665 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 16762.483333333334 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 17490.016666666666 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 21351.850000000002 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 21484.366666666665 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 20487.350000000002 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 21106.899999999998 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 19462.033333333336 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 31317.0 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 20519.683333333334 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 16725.366666666665 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 19188.816666666666 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 16182.066666666668 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 10603.566666666666 |
| GSM30791 | baseline control 02 | male, 275-300g | 8812.5 |
| GSM30792 | baseline control 03 | male, 275-300g | 10292.300000000001 |
| GSM30793 | baseline control 04 | male, 275-300g | 8850.0 |
| GSM30794 | baseline control 05 | male, 275-300g | 9363.1 |
| GSM30795 | baseline control 06 | male, 275-300g | 8466.8 |
| GSM30796 | baseline control 07 | male, 275-300g | 8424.933333333332 |
| GSM30797 | baseline control 08 | male, 275-300g | 10475.199999999999 |
| GSM30798 | baseline control 09 | male, 275-300g | 10547.833333333334 |
| GSM30799 | pain 01 | 9416.800000000001 | |
| GSM30800 | pain 02 | 9099.9 | |
| GSM30801 | pain 03 | 7703.033333333333 | |
| GSM30802 | pain 04 | 10896.566666666668 | |
| GSM30803 | pain 05 | 9409.199999999999 | |
| GSM30804 | FC 01 | 10398.800000000001 | |
| GSM30805 | FC 02 | 8645.1 | |
| GSM30806 | FC 03 | 9110.533333333333 | |
| GSM30807 | FC 04 | 8878.933333333332 | |
| GSM30808 | FC 05 | 8214.833333333334 | |
| GSM30809 | IFC 01 | 8232.966666666667 | |
| GSM30810 | IFC 02 | 8929.933333333332 | |
| GSM30811 | IFC 03 | 8371.300000000001 | |
| GSM30812 | IFC 04 | 8640.9 | |
| GSM30813 | IFC 05 | 10128.6 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 9165.166666666666 |
| GSM99801 | isoflurane 02 | male, 275-300g | 9995.033333333333 |
| GSM99802 | isoflurane 03 | male, 275-300g | 9876.133333333333 |
| GSM99803 | isoflurane 04 | male, 275-300g | 7905.0 |
| GSM99804 | isoflurane 05 | male, 275-300g | 9984.9 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 1027.799925 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 1204.469175 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 1119.0470249999998 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 1166.777075 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 1333.9345 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 1153.351 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 2019.287825 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 1860.176325 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 1086.736625 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 18.4741 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 18.3881 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 18.6169 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 18.4502 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 17.9532 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 17.9549 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 18.3253 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 18.0556 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 17.7514 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 17.8717 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 18.059 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 17.9218 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 17.9672 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 17.843 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 18.4267 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 18.2676 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 6161.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 6696.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 5633.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 5004.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 5399.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 4615.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 5676.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 4883.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 4156.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 8388.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 5709.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6540.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 5743.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6466.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6972.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 4144.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6729.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6085.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4248.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4406.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 5491.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 8549.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6158.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6431.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 6590.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3467.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 6134.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 6755.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 7750.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 7231.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 5933.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 7411.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6705.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 5895.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 7407.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 4099.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 406.72641 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 503.058838 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 373.036041 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 380.479034 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 3855.85 | |
| GSM5121 | Isoflurane single exposure control-2 | 2883.2000000000003 | |
| GSM5122 | Isoflurane single exposure control-3 | 2816.683333333333 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 2932.3999999999996 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 1555.6499999999999 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 2662.0333333333333 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 1037.85 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 3824.65 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 13.031739310833332 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 13.09799441 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 12.902675842083333 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 12.813366457083333 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 12.91334016375 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 12.986079947916666 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 13.86884100125 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 12.995063734999999 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 13.202931197083334 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 12.837265719583334 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 13.795161354166666 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 13.351318018333332 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 13.008606012083334 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 13.835636860416667 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 13.247326134583332 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 13.379418670416667 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 14.03713719625 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 13.653592730416666 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 13.642017390416669 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 13.0856056175 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 13.336983635416665 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 12.818551974999998 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 13.114525824166666 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 13.078109623749999 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.553873 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.933721 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.482688 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.08639 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.240915 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.369571 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.509895 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.670329 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.373392 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.076648 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.646171 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.734806 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.058757 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.13865 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.649201 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.69002 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.151348 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.573647 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.8228 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.06573 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.182429 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.4268 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.493426 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.620281 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 8627.382 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 9111.835333333333 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 10337.456326791667 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 19090.712848333333 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 37345.085292916665 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 9212.837417 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 13297.191042833336 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 13465.948007583334 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 13831.320277916668 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 14010.506923333332 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 15510.066989583334 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 21455.598352083332 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 17878.92217125 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 21587.942280416668 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 18865.721560833335 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 7710.554779208333 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 13.031739310833332 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 13.09799441 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 12.902675842083333 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 12.813366457083333 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 12.91334016375 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 12.986079947916666 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 13.86884100125 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 12.995063734999999 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 13.202931197083334 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 12.837265719583334 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 13.795161354166666 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 13.351318018333332 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 13.008606012083334 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 13.835636860416667 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 13.247326134583332 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 13.379418670416667 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 14.03713719625 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 13.653592730416666 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 13.642017390416669 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 13.0856056175 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 13.336983635416665 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 12.818551974999998 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 13.114525824166666 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 13.078109623749999 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 10337.456326791667 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 19090.712848333333 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 37345.085292916665 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 9212.837417 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 13297.191042833336 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 13465.948007583334 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 13831.320277916668 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 14010.506923333332 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 15510.066989583334 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 21455.598352083332 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 17878.92217125 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 21587.942280416668 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 18865.721560833335 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 7710.554779208333 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 2618.766666666667 | |
| GSM5084 | Control 2 | 2330.383333333333 | |
| GSM5085 | Control 3 | 2304.383333333333 | |
| GSM5086 | Control 4 | 2192.4500000000003 | |
| GSM5087 | Control 5 | 2103.35 | |
| GSM5090 | Control 6 | 2042.1166666666668 | |
| GSM5105 | Control 7 | 1885.7 | |
| GSM5106 | Control 8 | 2061.25 | |
| GSM5107 | Control 9 | 2193.75 | |
| GSM5108 | Halothane 10 exposure-1 | 1852.033333333333 | |
| GSM5109 | Halothane 10 exposures-2 | 1967.6666666666667 | |
| GSM5110 | Halothane 10 exposures-3 | 2068.4666666666667 | |
| GSM5111 | Halothane 5 exposures-1 | 1727.9166666666667 | |
| GSM5112 | Halothane 5 exposures-2 | 2124.016666666667 | |
| GSM5113 | Halothane 5 exposures-3 | 2675.9666666666667 | |
| GSM5114 | Isoflurane 10 exposures-1 | 1914.8833333333332 | |
| GSM5115 | Isoflurane 10 exposures-2 | 2021.7666666666667 | |
| GSM5116 | Isoflurane 10 exposures-3 | 2133.5333333333333 | |
| GSM5117 | Isoflurane 5 exposures-1 | 2092.15 | |
| GSM5118 | Isoflurane 5 exposures-2 | 2149.85 | |
| GSM5119 | Isoflurane 5 exposures-3 | 2212.75 | |
| GSM11379 | Control 10 | 2283.883333333333 | |
| GSM11380 | Control 11 | 2719.5499999999997 | |
| GSM11381 | Control 12 | 2205.2000000000003 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 10048.616666666667 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 13200.0 |
